IIF program, Policies and Practices Direction No. 1 of 1997

Definitions establish the instrument’s operating vocabulary. “Commonwealth program capital” denotes amounts invested in or provided to a licensed fund under the IIF program, while “private capital” denotes amounts that are not Commonwealth program capital (cl 3). The Board separately defines “Government sourced capital” as any amounts invested by entities funded directly or indirectly by the Commonwealth, a State or Territory, or persons who in the Board’s view are so substantially funded that their contributions should be treated as Government sourced capital, with an express carve-out permitting the Board to exclude amounts it considers inappropriate to treat as Government sourced capital (cl 19). The Board is given authority to elaborate on these definitions through the IIF guidelines (cl 7).

Licence and governance concepts: the Board awards licences to fund managers to create IIF licensed funds (cls 13, 21-24). The Direction distinguishes the roles of fund manager and the Board: fund managers make investment decisions (cl 33), but the Board may be asked to determine eligibility of investee companies (cl 33), may set licensing terms, and may place special conditions on licensed funds (cl 41). The term “Board may” is expressly defined to be permissive rather than mandatory (cl 3), indicating that many powers confer discretion.

Eligibility and exclusions: an “eligible investee company” must commercialise R&D results, be at seed, start-up or early expansion stage, operate in traded goods and services, produce a product/service intended for multiple sales to unrelated entities, have most employees and assets in Australia, and satisfy revenue caps (cl 26(a)-(g)). The Board is directed to exclude certain activities from eligibility, including re-lending, passive businesses, real estate, farm purchases and mining operations (cl 30). The Board can add other exclusions on generally applicable bases such as activity, corporate structure or industry (cl 32).

Funding mechanics and limits: the Board must provide in guidelines that Government sourced capital to private capital will not exceed 2:1, that at least 30% of private capital come from unrelated entities, and that an IIF licensed fund should generally provide funding only by equity purchase (cl 37(a), (d), (e)). Investment timing and concentration limits are prescribed, including investing at least 60% of committed capital within five years and caps on investment per company of $4,000,000 or 10% of committed capital unless the Board agrees otherwise (cl 37(f), (g)).

Reporting, valuation and audit: funds are subject to annual audited reporting within three months of the end of the fund’s year of income, audited by the Commonwealth Auditor-General or an approved auditor (cl 39). The Board must set policies and methodologies to ensure consistent, transparent and realistic valuations reflecting generally accepted practice where practicable (cl 44). The Board may request information in any format for monitoring, financial assessment, auditing, evaluation and compliance purposes (cl 40).

Return distribution and term: the distribution waterfall requires return of capital in proportion to amounts subscribed, payment of a notional interest to investors calculated at the ten year bond rate prevailing on the date the Board made the offer, and that residual surplus be split with 10% to the Commonwealth and 90% among other investors and the fund manager (cl 46). The fund is to be wound up after ten years from the date Commonwealth program capital is first contributed, subject to extensions for orderly wind-down or other Board-determined reasons (cl 48).

Enforcement and remedies: the Board may place funds under special conditions where insolvency, breaches, failure to meet milestones or changes to key personnel occur, and may require remedial steps such as replacement of a fund manager, divestment, restrictions on investment, cost reimbursement or recruitment of additional staff (cls 41-42). The Board must make provision for the removal of fund managers for a range of grounds (cl 51) and for liquidation of fund assets where appropriate (cl 52).

Procedural and discretionary features: the Board may change IIF guidelines at any time, including during a licensing round and after applications have been received, with the amended guidelines applying notwithstanding the date of application (cl 8). The Board may include IIF guidelines within licence agreements as it thinks fit (cl 9). The Board may levy fees to recover assessment costs and to cover determinations about eligibility (cls 11, 35). These concepts create a regime where statutory rules set floors and ceilings, but the Board retains broad contractual and administrative discretion to define and enforce the practical terms of licences and fund operation.

Directly regulated parties: the primary regulated entities are fund managers who apply for and may receive IIF licences, and IIF licensed funds that receive Commonwealth program capital. The Board’s actions target fund managers in terms of eligibility criteria, required disclosures, key personnel expectations, limits on fees and services and potential removal (cls 15, 17, 49-50, 51). Licensed funds are required to comply with investment limitations, reporting, valuation, audit and distribution rules (cls 26, 37, 39-40, 44-48).

Investors and capital providers: private investors who commit capital to IIF licensed funds are affected by requirements that certain proportions of private capital be from unrelated parties (cl 37(d)), by constraints on transfers and withdrawals (cl 53), and by the distribution and priority mechanics that govern returns (cl 46). The Board has power to treat certain contributors as Government sourced capital when those contributors are substantially funded by governments (cl 19), which can recharacterise the status of funds contributed by bodies receiving public monies and thereby affect the permitted private-to-government ratio and distribution entitlements.

Investee companies: companies receiving funding from IIF licensed funds must meet the eligibility criteria at the time of the first investment, including revenue caps and Australian presence (cl 26). Eligible investee companies will be subject to requirements about the application of funds to commercialisation activities and may face limitations if related to fund managers or large private contributors (cls 26, 31, 37(l)).

State, Territory and Commonwealth bodies: entities funded by Commonwealth, State or Territory sources fall within the Direction’s scope as potential providers of Government sourced capital (cl 19(a)). The Direction also requires audits be performed by the Commonwealth Auditor-General or an approved auditor (cl 39), which engages Commonwealth oversight structures.

Professional service providers and auditors: auditors who will audit licensed funds are affected because the Direction requires either the Auditor-General or an approved auditor to audit the funds’ reports (cl 39). Legal, accounting and fund administration professionals will likely be engaged to prepare audited financial statements, to assist in valuations that must meet Board-prescribed methodologies (cl 44), and to advise on compliance with licence terms and conflicts rules (cl 37(i)).

The Board and Department: the Board and the Department (as defined at cl 3) carry administrative burdens mandated by the Direction, including establishing and amending IIF guidelines, assessing applications, making determinations about eligibility, administering drawdown processes and, where necessary, imposing conditions, removing managers and enforcing licence terms (cls 6-9, 11-14, 33-35, 38, 41, 51).

Indirect and market effects: the Direction targets the early-stage venture capital market by intervening in fund-level structures, investment terms and monitoring arrangements (cl 5(a)-(d)). This may influence private fund managers’ behaviour when considering whether to allocate resources to apply for an IIF licence, the structure of fundraisings to ensure at least 30% private capital from unrelated parties (cl 37(d)), and the use of equity rather than debt (cl 37(e)). Companies and investors outside the IIF program are indirectly affected through competitive dynamics and possible signalling about government priorities in early stage technology commercialisation (cl 5).

Stakeholder rights and obligations: investors have contractual rights determined by licence agreements and distribution terms set by the Board (cl 22, 46-47). Fund managers have operational rights to make investments, but those rights are conditioned by reporting duties, limitations on investment instruments, conflict rules and Board powers to impose conditions or remove managers (cls 33, 37(c), (h)-(k), 39-42, 51).

Board duties and rights: the Direction imposes several duties on the Board to follow prescribed processes, to develop and publish IIF guidelines (cls 6-7), to have regard to set policy objectives in administering the program (cl 5), to publicise closing dates for licensing rounds (cl 10), and to consider applications as soon as practicable (cl 12). The Board has rights to levy fees to recover costs of assessing applications and determinations (cls 11, 35), to make licence offers and prescribe conditions for acceptance (cls 21-24), to determine drawdown processes and withhold drawdowns where appropriate (cl 38), and to place funds under special conditions, replace fund managers, or liquidate funds in specified circumstances (cls 41-42, 51-52). The Board may also change the IIF guidelines at any time, including during licensing rounds, with the amendment applying notwithstanding prior application dates (cl 8). The Board’s discretion is broad: terms are often left to be fixed in the IIF guidelines or in licence agreements as the Board thinks fit (cl 6, 9, 20).

Fund manager duties and rights: fund managers seeking licences must meet information and capability criteria in the IIF guidelines, including demonstrating access to private capital, relevant investment and portfolio management experience, provision of business plans and details of key personnel, and commitment to training Australian-based staff (cls 15, 17). On acceptance of an offer, managers must execute a licence agreement, evidence committed private capital, and comply with other Board requirements (cl 22). Once licensed, managers have the right to make investment decisions for the fund (cl 33), subject to restrictions requiring arm’s length transactions (cl 37(h)), conflict-avoidance duties and notification obligations for unavoidable conflicts (cl 37(i)), limits on debt raising (cl 37(c)), and obligations to ensure funds are invested per eligibility criteria (cl 26). Managers are obliged to supply audited reports and other information on request (cls 39-40), adhere to valuation policies (cl 44) and accept Board-imposed special conditions or removal if circumstances in cl 41 or cl 51 obtain.

Investor rights and obligations: investors have rights to distributions in proportion to their subscriptions (cl 46(b)), to a notional interest payment equal to the ten year bond rate prevailing on the date the Board made the offer (cl 46(c)(i)), and to their share of surplus allocated after those payments (cl 46(c)(ii)). Investors also face obligations, including providing committed capital, meeting any conditions in licensing agreements, and complying with provisions governing influence, transfers and withdrawals (cl 22, 37(j), 53). Investors must not influence individual investment decisions of the fund manager (cl 37(j)).

Eligible investee company obligations: investee companies must be engaged in commercialising R&D results and meet stage, sector, Australian presence and revenue requirements at the time of first investment (cl 26). Funds provided must be applied towards commercialisation activities such as marketing, production, product development or prototyping (cl 37(l)). Investee companies that are related to the fund manager or to major private contributors are generally excluded unless the Board approves (cl 31).

Auditor rights and duties: auditors either from the Auditor-General’s office or approved auditors must carry out audits on an IIF licensed fund’s reports as specified by the Board (cl 39). The Board also may request additional information for evaluation, monitoring and auditing purposes (cl 40).

Contractual relationship: many operational duties and rights flow from licence agreements or other contractual documents the Board enters into with fund managers, where the Board may incorporate guidelines and impose conditions, and those agreements will contain the operational contractual obligations and remedies (cl 4, 9, 22).

The Direction itself does not create criminal penalties; enforcement is implemented by contractual and administrative mechanisms controlled by the Board, as set out in the IIF guidelines, licence agreements and other contractual documents. The instrument repeatedly instructs the Board to "make provision" in its guidelines and contractual documents for actions the Board may take, thereby creating enforcement mechanisms through contract terms (cls 6-9, 20, 22, 41, 51, 52). Key enforcement tools include the following.

Imposition of special conditions and remedial measures: the Board may impose additional conditions on a licensed fund where, in the Board’s opinion, the fund or its manager is or may become insolvent or suffer substantial loss of capital, breaches guidelines or contractual obligations, fails to achieve milestones, or key personnel changes occur (cl 41). The Board lists specific possible measures it may require, including replacement of a fund manager, divestment of investments, limitations on future investments or debt raising, reimbursement of costs associated with correcting the circumstance, and recruitment of additional staff (cl 42). The Board must consult entities contributing private capital when placing additional conditions, excluding the fund’s manager and associates (cl 41).

Manager removal and fund liquidation: the Board must include in guidelines contractual provisions for removal of fund managers where specified grounds obtain, including insolvency, breaches of guidelines, failure to meet milestones, non-compliance with special conditions, departure of key personnel, breaches of law, or other circumstances the Board thinks fit (cl 51). The Board must provide for liquidation of fund assets prior to the ten-year wind-up in circumstances such as compliance with a court order, when the Board considers insolvency or substantial loss likely, when investors request liquidation, or other circumstances the Board deems fit (cl 52).

Withholding drawdown and withholding of funding: the Board may, where appropriate, withhold Commonwealth program capital from being drawndown, and must determine drawdown processes in guidelines or contractual documents (cl 38(b)). Withholding drawdowns functions as a levers to enforce compliance or respond to perceived fund manager weaknesses.

Contractual recourse and fee conditions: the Board may levy fees for application assessment and for determinations about investee eligibility, and may refuse to consider applications or make determinations until fees are paid (cls 11, 35). The Board can require acceptance of licence offers within six months, otherwise the offer lapses and the Board may re-offer licences to other applicants (cls 23-24). These contractual conditions create enforcement incentives by linking administrative privileges to compliance.

Valuation and audit enforcement: the Board must set valuation methodologies and requires audited reports to be provided within three months of year-end unless otherwise specified (cls 39, 44). Failure to provide such information will be a breach of licence terms and contractually actionable. Audits are to be performed by the Auditor-General or an approved auditor, increasing the potential for Commonwealth scrutiny and administrative action (cl 39).

Notification and conflicts compliance: parties must notify the Board within 30 days of entering into any conflict-of-interest transaction and provide details, creating an enforcement trigger for Board review (cl 37(i)). Failure to notify will be a breach of licence agreement and attract contractual remedies.

Distribution mechanics and priority: the distribution waterfall is contractualised; the Commonwealth has no priority as to distributions, capital is returned in proportion to subscription, interest is paid at a specified rate, and surplus is allocated with 10% to the Commonwealth and 90% to other investors and the fund manager (cl 46). Any departures from this waterfall must be agreed with the Board and documented in licence agreements, giving the Board an enforcement role to ensure distributions conform to its determinations (cl 47).

Court orders and statutory compliance: the Board must provide for liquidation where required by a court order (cl 52(a)), signalling that enforcement ultimately can involve judicial processes when invoked, but the Direction itself focuses on administrative and contractual remedies exercisable by the Board.

References to the Act and other statutes: the Direction expressly operates under the Industry Research and Development Act 1986, and frequently refers to terms defined in the Act (for example “R&D activities” is defined by reference to s 4(1) of the Act at cl 3). The Direction states that references to Acts or instruments are to those Acts as amended or replaced from time to time (cl 3).

Corporations Law interactions and corporate definitions: several definitions and compliance requirements cross-reference the Corporations Law. “Related entity” is defined by reference to section 9 of the Corporations Law (cl 3). Investment exclusions and restrictions reference section 50 of the Corporations Law when defining related companies (cl 31), and control is referenced to section 294B of the Corporations Law (cl 31(c)). Conflicts-of-interest transactions must demonstrate arm’s length dealings consistent with Part 3.2 of the Corporations Law (cl 37(i)). These cross-references integrate corporate law tests on related parties, control and conflicts into the IIF operational regime and import legal standards and potential fiduciary or statutory duties that apply under corporate law into licence administration and oversight.

Higher Education Funding Act: the definition of “qualifying enterprise” references institutions of higher education specified in s 4(1) of the Higher Education Funding Act 1988 (cl 3). This creates a channel for certain public institutions to qualify for specific treatment under the Direction, subject to the Board’s assessment.

Audit and public audit frameworks: the Direction requires audited reports to be signed off by the Commonwealth Auditor-General or an auditor approved by the Auditor-General (cl 39). That requirement brings licensed funds into the orbit of Commonwealth audit standards and potentially the Auditor-General’s processes, aligning financial reporting and accountability with public auditing frameworks.

Common law and contract: the Direction delegates operational enforcement to licence agreements and other contractual documents (cl 4, 9, 22). Those contractual relations will be interpreted under general contract law and may be enforced by courts. The Direction allows court orders to compel liquidation where applicable (cl 52(a)), indicating an intersection with judicial powers.

Administrative law and discretion: the Board’s broad discretionary powers, including amending guidelines during licensing rounds (cl 8), withholding drawdowns (cl 38), treating contributors as Government sourced capital (cl 19) and imposing special conditions (cl 41), will engage principles of administrative law where decisions may be reviewable under judicial review if they are made pursuant to statutory power or public law duties, or where procedural fairness, reasonableness, or other review grounds are raised. The Direction itself does not specify review mechanisms.

Tax, securities and fundraising laws: the Direction does not itself address taxation, securities offering laws, or fundraising disclosure obligations. However, fund structures and capital raises (cl 37(b), (c), (d)) will interact with taxation law, the Corporations Act fundraising and disclosure regimes, and state-based laws controlling investor protection. Where the Board approves structures or imposes restrictions, fund managers will need to ensure compliance with applicable tax and securities laws, but those interactions are not specified within the Direction.

State or Commonwealth funding relationships: the Direction treats as Government sourced capital contributions from entities funded directly or indirectly by the Commonwealth, a State or Territory (cl 19(a)). That rule means contributions from certain public bodies, or from entities substantially funded by public money, may be recharacterised, affecting the permissible public-private ratio and distribution entitlements. This recharacterisation authority operates within the broader statutory framework where public funding status is defined by the Board’s assessment.

Corporations Law references, Higher Education Funding Act reference, and requirement for audit by the Auditor-General create concrete legal cross-currents. Licence agreements fill the gap between statutory direction and day-to-day regulatory obligations, and any disputes or enforcement will engage contract law, administrative law and potentially judicial orders as the Direction contemplates (cl 52(a)).

The instrument as compiled records an initial gazettal commencement on the day particulars were published in the Gazette, with a note indicating the compilation was prepared on 18 September 2013 taking into account amendments up to IIF program Round One, Policies and Practices (Amendment) Direction No. 1 of 1999 (F2008B00714) (front matter). The Direction contains an appended Note and tables recording subsequent instruments, registration numbers and commencement dates.

The Note to the Direction shows a Table of Instruments listing at least two registration entries. The first entry is titled "R&D Start Program, policies and practices of the IR&D Board in relation to the Innovation Investment Fund (IIF) Program Direction No. 1 of 1997", with FRLI registration number F2008B00470, registered 5 August 2008 and noting commencement 22 August 1997 (date of Gazettal). The second entry records the Direction and an amendment: "R&D Start Program, policies and practices ... (Amendment No. 1 of 1998) IIF program Round One, Policies and Practices (Amendment) Direction No. 1 of 1999" with registration numbers F2008B00471 and F2008B00714, registered 5 August 2008 and 28 October 2008, and commencements dated 26 August 1998 and 8 December 1999 respectively (the table entry shows both dates of Gazettal) (note table).

A Table of Amendments follows, using abbreviated codes indicating provision affected and how affected. The table lists entries for the Title, Clause 3 (twice) and Clause 26(g) among the provisions affected, and denotes changes with codes such as "rs." (repealed and substituted), "am." (amended), and "ad." (added). The table cites specific FRLI instrument numbers F2008B00471 and F2008B00714 as responsible for amendments or substitutions to those clauses. The compiled HTML table in the source shows that Clause 3 and Clause 26(g) were subject to amendment and substitution by those instruments.

The Direction’s text also includes a note in cl 3 that a reference to an Act or other instrument is to that Act as amended or replaced from time to time, which carries forward the expectation that subsequent legislative changes to underlying statutes (for example, the Corporations Law being replaced by or integrated into the Corporations Act) will apply to terms referenced by the Direction.

Practitioners should therefore treat the Direction as a living instrument with recorded amendments and expect that operational details in the IIF guidelines and licence agreements may reflect or implement those amendments. The Direction’s compilation identifies at least two amendment instruments by FRLI registration numbers and dates, and the Table of Amendments indicates specific clauses were altered or substituted.

The Direction itself does not include a record of court decisions or litigation. The text and accompanying notes provide amendment and registration history but do not name any cases or report judicial determinations. Because the Direction is primarily a policy and contractual framework authorising the Board to enter licence agreements and impose contractual terms, disputes arising under the Direction would principally present as contractual disputes, administrative law challenges to Board decisions, or matters falling within corporate or insolvency law, depending on the issue. The Direction contemplates court involvement in at least one respect: the Board must make provision for liquidation of fund assets in the event the Board is required to do so in compliance with a court order (cl 52(a)). That provision implies that judicial orders can directly affect a fund’s status, but the Direction does not report any such orders.

Operationally, potential litigation or review questions that could arise from the Direction include:

• Contractual disputes between fund managers, investors and the Board arising from licence agreements and distributions, given that licences are to be executed on terms acceptable to the Board (cl 22), and the distribution mechanism is narrowly specified (cl 46-47).

• Administrative law challenges to Board decisions where the Board exercises statutory or quasi-public functions in ways that may be challenged on grounds such as procedural fairness, jurisdictional error, irrationality, or unreasonableness, for example where the Board exercises its broad discretionary powers to re-characterise contributions as Government sourced capital (cl 19), amend guidelines during licensing rounds (cl 8), withhold drawdowns (cl 38), place special conditions (cl 41), or remove fund managers (cl 51).

• Insolvency and corporate law litigation arising when a fund or manager is alleged to be insolvent or when control or related-party transactions (which the Direction references to Corporations Law sections) are contested (cls 31, 51-52).

• Disputes arising from valuation methodologies and reported asset values, since the Board requires valuation policies that reflect generally accepted practice where practicable, and valuations affect distributions and performance metrics (cl 44).

The Direction does not list prior litigation, and no cases are named in the instrument. Practitioners assessing litigation risk should review licence agreements, the IIF guidelines published by the Board, the Act under which the Direction was issued, and any subsequent relevant legislative changes or case law concerning Board actions. Because the Direction embeds many enforceable terms into contractual documents rather than directly creating penal sanctions, most enforcement and dispute resolution is likely to proceed through contractual mechanisms and civil litigation, supplemented by administrative law remedies where public law powers are invoked.

High Board discretion and rule changes during application rounds. Clause 8 explicitly permits the Board to amend the IIF guidelines from time to time, including during the currency of any licensing round and after the applications have been received. The amended guidelines apply to that licensing round and to those applicants notwithstanding the date on which applications were made. Practically, that means applicants face regulatory uncertainty: selection criteria, disclosure requirements, investment limits or fee caps could be changed after application lodgement and be applied to existing applications (cls 6-9). This creates implementation risk and compliance cost for applicants who must track and adapt to evolving requirements mid-process.

Definition-based recharacterisation risk. Clause 19 gives the Board authority to treat amounts as Government sourced capital where those amounts are invested by entities funded directly or indirectly by Commonwealth, State or Territory, or invested by persons substantially funded by public sources in the Board’s opinion. The Board also retains the discretion to exclude any amount it considers inappropriate to treat as Government sourced capital. This two-way discretion allows the Board to recharacterise contributions after the fact on a fact-specific assessment, which can alter the permissible Government-to-private ratio (cl 37(a)) and affect distribution shares and compliance with the 2:1 cap. Fund managers and investors must therefore document funding provenance carefully and anticipate that the Board may scrutinise and reclassify capital sources.

“Board may” is permissive, not mandatory. The Direction defines “Board may” as permissive (cl 3). While that signals the Board has decision-making flexibility, it also means that many protections or benefits are not guaranteed. For instance, the Board may choose not to award a licence even if an applicant satisfies the guidelines (cl 14), and may decline to make determinations or to provide clarifications unless fees are paid (cl 35). Applicants should not assume an entitlement to licence or determinations.

Revenue and stage tests for investees. The eligible investee company definition requires average annual revenue over the previous two years not to exceed $4 million and that revenue in either year not exceed $5 million, excluding abnormal items (cl 26(f)). This can exclude otherwise promising firms that have transient revenue spikes, and fund managers must apply careful revenue accounting for eligibility. The definition requires a majority of employees and assets by value to be inside Australia at first investment (cl 26(e)), which can penalise firms with distributed operations or offshore asset holdings.

Investment instrument constraints. Funds are generally restricted to equity purchases, with limited exceptions for short-term loans to existing investees or other uses approved by the Board (cl 37(e)). The Direction also restricts debt raising by funds except for short-term liquidity or leasing and only with the Board’s consent (cl 37(c)). Fund managers who rely on mezzanine instruments or structured hybrids will need Board approval, and may face constraints that alter expected portfolio strategies.

Concentration and per-company caps. Clause 37(g) limits investment in any eligible investee company to $4,000,000 or 10% of committed capital, whichever is lesser, unless the Board agrees otherwise. That constrains portfolio concentration and follow-on investment strategies, potentially requiring multiple funds or Board approvals for larger rounds.

Distribution waterfall quirks. Clause 46 sets a distribution sequence: capital is returned in proportion to amounts invested, investors are paid interest at the ten year bond rate prevailing on the date the offer of a licence is made, and any surplus is split 10% to the Commonwealth and 90% among other investors and the fund manager. The Commonwealth has no priority as to distributions (cl 46(a)), but the specified interest payment uses a fixed bond rate tied to the offer date. Fund managers and private investors need to model the implied public sector return and how carry is allocated, because the Board determines the split among other investors and the fund manager, taking into account distribution mechanisms agreed between the manager and other investors (cl 47).

Reporting and audit timing. Audited reports are due within three months of the end of the fund’s year of income unless otherwise specified (cl 39), and the audit must be by the Auditor-General or an approved auditor. That timing may be tighter than private fund reporting cycles and will require coordination with public auditing processes. The Board may request information in any format for monitoring and evaluation (cl 40), creating ongoing administrative burdens.

Conflicts and related party restrictions. The Direction forbids or requires Board approval for investments in companies related to the fund manager, related to entities providing over 10% of private capital, controlled by an entity providing private capital, or having directors who are associates of the fund manager (cl 31). The fund must avoid conflicts, and unavoidable conflicts require notification to the Board within 30 days and demonstration that transactions were arm’s length consistent with Part 3.2 of the Corporations Law (cl 37(i)). These rules can complicate common venture capital structures involving affiliated operating entities or anchor investors.

Funding composition requirements. The requirement that at least 30% of private capital come from entities not associated with the fund manager (cl 37(d)) can complicate fundraising where managers rely heavily on familiar institutional partners or family offices. The Board may impose additional diversity requirements in the guidelines. Fund managers must source a minimum base of unrelated private capital to qualify.

Key personnel dependence. The Direction emphasises key personnel in applications and allows the Board to place conditions or remove a manager if key personnel depart as described in the application (cls 15(a), 41(d), 51(e)). This means that personnel retention and contractual commitments with named individuals are material to the licence and may trigger remedial measures upon departure.

Amendment and transitional risk. The compiled instrument records multiple amendments and substitution entries (see the Table of Amendments). Combined with clause 8, which permits guideline changes to apply even to pending applications, this generates transitional ambiguity that increases compliance and legal advisory costs.

Fee triggers. The Board may levy fees to recover assessment costs and may refuse to assess applications or make determinations until fees are paid (cls 11, 35). Fee amounts must not exceed costs incurred, but there is a cashflow implication for applicants and licensed funds.

Valuation standard and dispute exposure. Clause 44 requires the Board to make provisions in the guidelines for valuation methodologies that reflect generally accepted practice where practicable. The omission of a single, mandatory valuation standard and the “where practicable” caveat creates scope for disputes over valuations and hence distributions and performance measurements.

Practical checklist for applicants and fund managers

1. Read the IIF guidelines and licence form carefully, and monitor amendments. The Direction permits the Board to amend the IIF guidelines at any time and apply changes to current licensing rounds and applications (cl 8). Maintain a process to capture guideline updates, and ensure legal counsel reviews any revised terms for material changes before acceptance or closing.

2. Demonstrate access to privately sourced capital. The IIF guidelines must require applicants to show they can access the level of private capital requested (cl 15(a)). Prepare binding commitments or letters of intent from unrelated private investors to meet the 30% unrelated private capital floor (cl 37(d)). Document the source of each contribution to withstand potential Board recharacterisation under cl 19.

3. Prepare detailed personnel documentation. Provide full details of key personnel, their roles, terms of employment and responsibilities, and consider fixing key personnel commitments in written contracts to minimise the risk of Board-imposed sanctions if personnel leave (cls 15(a), 17(a), 41(d), 51(e)).

4. Provide a business plan meeting the required elements. Include timing of investments, the proposed level of annual fund management fees, and the scope of management services for the fee (cl 17(d)). Be ready to justify fee levels against Board-prescribed caps and reasonableness criteria (cl 49).

5. Design the fund structure to meet capital composition and debt constraints. Ensure fund documents show that Government sourced capital will not exceed a 2:1 ratio to private capital, and that at least 30% of private capital is from non-associated parties (cl 37(a), (d)). Avoid raising material debt financing or debt-like equity without Board consent (cl 37(c)).

6. Draft investee selection and monitoring processes to meet eligibility tests. Implement processes to ensure investees meet cl 26 criteria at the time of first investment, including Australian employee and asset location tests and revenue caps. Document revenue calculations excluding abnormal items to avoid disputes (cl 26(f)).

7. Be prepared to invest largely by equity and respect concentration limits. Structure transaction documents primarily as equity purchases and ensure per-company exposure does not exceed $4,000,000 or 10% of committed capital without prior Board approval (cl 37(e), (g)).

8. Implement conflict avoidance and arm’s length procedures. Adopt conflict policies and transaction documentation to demonstrate arm’s length terms consistent with Part 3.2 of the Corporations Law when related party transactions cannot be avoided. Notify the Board within 30 days of any conflict-of-interest transaction, and prepare contemporaneous evidence supporting fair market terms (cl 37(i)).

9. Compliance with reporting and valuation obligations. Prepare to deliver audited reports within three months of the fund’s year of income end, using an auditor acceptable to the Auditor-General where required (cl 39). Adopt valuation methodologies aligned with the Board’s guidelines, documenting assumptions and comparables to reduce valuation disputes (cl 44).

10. Model distributions and timing constraints. Build financial models that incorporate the Board-determined distribution waterfall: proportionate return of capital, interest at the ten year bond rate as at offer date, and a surplus split with 10% to the Commonwealth and 90% to other investors and the fund manager. Ensure investor agreements allocate carry in a manner the Board can reconcile with its determination powers (cls 46-47).

11. Limit management-related service charges to market rates and optional provision. Ensure any management services charged to portfolio companies are optional, no more than market rates, and open to third party provision, as required by cl 50. Maintain documentation showing how fees compare with market.

12. Prepare to meet drawdown and investment timeline requirements. Plan to invest at least 60% of committed capital within five years of licence grant unless Board approvals extend the timeframe. Keep investment pacing reports and forecasting models ready for Board review (cl 37(f)).

13. Anticipate Board monitoring and special conditions. Maintain regular communications with investors and the Board, promptly report material events, and prepare contingency plans for replacement of the fund manager or divestment scenarios the Board may impose under cl 42.

14. Negotiate licence acceptance carefully. When the Board offers a licence, acceptance requires notifying the Board in writing, demonstrating private capital has been committed, executing the licence agreement in acceptable form, and complying with other requirements specified in the offer (cl 22). Ensure timelines for acceptance and funding commitments are achievable, and understand that offers lapse after six months if not accepted (cl 23).

15. Control documentation and investor agreements. Draft investor side letters and subscription agreements reflecting the Board’s distribution and governance requirements, and include remedies and representations about source of funds to mitigate risk of recharacterisation (cl 19, cl 46).

16. Maintain records to respond to determinations and fee requests. The Board may charge fees to recover costs for determinations about whether a company is an eligible investee company and may refuse to make determinations until fees are paid (cl 35). Maintain records that will support determinations and budget for potential administrative fees.

17. Engage appropriate auditors and advisers early. Given the requirement for Auditors acceptable to the Auditor-General and the specific valuation stipulations, secure audit and valuation advisers experienced with public-sector funded or hybrid funds.

18. Understand withdrawal and transfer conditions. Licence agreements will include conditions for investor withdrawals, transfer of interests and failure of investors to deliver committed capital (cl 53). Include mechanisms for remedial funding or dilution in investor documents to handle under-delivery.

19. Build legal and governance compliance frameworks. Implement internal compliance monitoring, escalation procedures for potential breaches, and a plan for rapid engagement with the Board if the fund faces insolvency, key personnel loss, or potential breaches that could trigger Board action (cls 41, 51, 52).

20. Seek pre-licence advice on investee eligibility where appropriate. Fund managers may request Board determinations on whether a company is an eligible investee company. Use this process where investee eligibility is borderline and budget for fees the Board may levy for making determinations (cl 33-35).

Following these steps will position applicants and licensed fund managers to comply with the Direction’s structural, reporting and behavioural requirements. Legal counsel should be engaged to tailor contractual terms to reflect Board-prescribed constraints and to mitigate the specific discretionary and operational risks highlighted by the Direction.